| Page 2016 | Kisaco Research
 
21-22 Mar 2018
Kansas City, USA
The Animal Microbiome Congress USA brings together leading veterinary researchers, innovative biotechnology companies, feed and strain manufacturers, animal breeders and producers, pharmaceutical companies, regulatory bodies, and cutting-edge solution providers to understand the latest research focusing on manipulating the animal microbiome, form successful product development strategies, and facilitate collaborations and business partnering.Techniques and products that manipulate the animal microbiome are set to be the next frontier in superior disease therapeutics, diagnostics, and nutrition in livestock, companion animals, and aquaculture. The conference will showcase unpublished data, new technologies, and translational case studies presented by leading academic and industry experts. Our ‘MEETING MOJO’ platform will allow you to schedule meetings across the two conference days to facilitate future collaborations and business partnering. 
 

Peter McCarthy

Practice Leader Commercial & Strategy
Stonehaven Consulting

Mr. McCarthy is now in his 7th year at Henry Schein, Inc. He is currently the Company's President, Global Animal Health Group, as well as a member of Henry Schein's Executive Management Committee.

Mr. McCarthy oversees Henry Schein's animal health business, which spans 24 countries including the United States, Australia, New Zealand, Canada, China, Malaysia, Brazil and 17 countries in Europe.

Peter McCarthy

Practice Leader Commercial & Strategy
Stonehaven Consulting

Peter McCarthy

Practice Leader Commercial & Strategy
Stonehaven Consulting

Mr. McCarthy is now in his 7th year at Henry Schein, Inc. He is currently the Company's President, Global Animal Health Group, as well as a member of Henry Schein's Executive Management Committee.

Mr. McCarthy oversees Henry Schein's animal health business, which spans 24 countries including the United States, Australia, New Zealand, Canada, China, Malaysia, Brazil and 17 countries in Europe.

Before assuming his current position, Mr. McCarthy held key roles at Henry Schein with increasing responsibilities, including President, Henry Schein Animal Health, Europe, and President, Henry Schein Animal Health, International.

Prior to joining Henry Schein, Mr. McCarthy worked at Schering-Plough Animal Health (now Merck Animal Health), serving as Senior Director, Global Operations and General Manager, China. Mr. McCarthy also worked at Wyeth/American Cyanamid for 14 years, helping to grow the human pharmaceutical business.

Mr. McCarthy holds a degree in Applied Biology from the University of Hertfordshire in the U.K., and previously has served as a Member of the Board of the International Federation for Animal Health Europe, and the International Association Executive Animal Health Study Center, CEESA, based in Belgium. Mr. McCarthy is also a graduate and member of the Chartered Institute of Marketing (CIM), which is located in the U.K.

 

Pascale Jordan

Business Development Director
Bio-Sourcing

Pascale Jordan got her PhD in Molecular and Cellular Biology from the Orsay University in France. She has nearly 20 years of experience in the Biotech/Pharma Industry, both Human and Animal Health. Pascale has served in a variety of  roles, including Financial Analyst in Merchant Bank and Business Development Manager at Inserm Transfert, one of the leading Tech Transfer Office in France.  Her last position was Business Development Director at Zoetis for the EuAfME region. She is now working as Business Development Director at Bio-Sourcing.

Pascale Jordan

Business Development Director
Bio-Sourcing

Pascale Jordan

Business Development Director
Bio-Sourcing

Pascale Jordan got her PhD in Molecular and Cellular Biology from the Orsay University in France. She has nearly 20 years of experience in the Biotech/Pharma Industry, both Human and Animal Health. Pascale has served in a variety of  roles, including Financial Analyst in Merchant Bank and Business Development Manager at Inserm Transfert, one of the leading Tech Transfer Office in France.  Her last position was Business Development Director at Zoetis for the EuAfME region. She is now working as Business Development Director at Bio-Sourcing.

 

Kathrin Ladetzki-Baehs

Managing Director
Adivo

Dr. Kathrin Ladetzki-Baehs joined MorphoSys > 10 years ago as a scientist. Following several years of intense laboratory work in antibody generation as a project team leader, she became an alliance manger in 2012.

Today, Kathrin (Director at MorphoSys) coordinates multiple therapeutic antibody projects in close collaboration with international external partners at MorphoSys.

Kathrin Ladetzki-Baehs

Managing Director
Adivo

Kathrin Ladetzki-Baehs

Managing Director
Adivo

Dr. Kathrin Ladetzki-Baehs joined MorphoSys > 10 years ago as a scientist. Following several years of intense laboratory work in antibody generation as a project team leader, she became an alliance manger in 2012.

Today, Kathrin (Director at MorphoSys) coordinates multiple therapeutic antibody projects in close collaboration with international external partners at MorphoSys.

Kathrin is a pharmacist and received the PhD from Ludwig Maximilians University Munich. Two dogs are beloved family members in Kathrin’s home. As one the dogs got diagnosed with canine cancer, Kathrin came up with the idea to transfer the whole expertise and knowledge of phage display, library generation and antibody generation from MorphoSys into the veterinary field. Since then she is responsible for all activities necessary to found adivo.

 

Karin Hoelzer

Senior Officer, Health Programs
The Pew Charitable Trusts

Karin Hoelzer is a senior officer in health programs supporting Pew’s safe food and antibiotic resistance projects.  Hoelzer, a veterinarian by training, focuses on research and policies related to foodborne pathogens, the use of antibiotics in animals, and other public health risks related to the food supply.  

Karin Hoelzer

Senior Officer, Health Programs
The Pew Charitable Trusts

Karin Hoelzer

Senior Officer, Health Programs
The Pew Charitable Trusts

Karin Hoelzer is a senior officer in health programs supporting Pew’s safe food and antibiotic resistance projects.  Hoelzer, a veterinarian by training, focuses on research and policies related to foodborne pathogens, the use of antibiotics in animals, and other public health risks related to the food supply.  

Before joining Pew, Hoelzer worked at the U.S. Food and Drug Administration, where she developed and led risk assessments and conducted systematic reviews and meta-analyses on a variety of issues, such as drug residues in dairy products and Listeria monocytogenes in retail delicatessens. Previously, she was a research associate at Cornell University, where she traced the transmission of pathogens between livestock and humans.

Hoelzer holds doctorates in veterinary medicine from the University of Veterinary Medicine in Hannover, Germany and comparative biomedical sciences from Cornell University. She has received numerous honors and awards, including a Morris Animal Foundation fellowship training grant, and is the author of many peer-reviewed publications. Hoelzer is a member of the American Veterinary Medical Association, the Society for Risk Analysis, and the International Association for Food Protection. She serves as scientific editor for the Elsevier journal Research in Veterinary Science.